IL99012A - N-sulfonylindoline derivatives their preparation and pharmaceutical compositions containing them - Google Patents

N-sulfonylindoline derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL99012A
IL99012A IL9901291A IL9901291A IL99012A IL 99012 A IL99012 A IL 99012A IL 9901291 A IL9901291 A IL 9901291A IL 9901291 A IL9901291 A IL 9901291A IL 99012 A IL99012 A IL 99012A
Authority
IL
Israel
Prior art keywords
group
dcm
alkyl
compound
mixture
Prior art date
Application number
IL9901291A
Other languages
English (en)
Other versions
IL99012A0 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Priority to IL11493491A priority Critical patent/IL114934A/en
Publication of IL99012A0 publication Critical patent/IL99012A0/xx
Publication of IL99012A publication Critical patent/IL99012A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL9901291A 1990-07-31 1991-07-30 N-sulfonylindoline derivatives their preparation and pharmaceutical compositions containing them IL99012A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11493491A IL114934A (en) 1990-07-31 1991-07-30 N-substituted sulfonylaminobenzene derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009778A FR2665441B1 (fr) 1990-07-31 1990-07-31 Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.

Publications (2)

Publication Number Publication Date
IL99012A0 IL99012A0 (en) 1992-07-15
IL99012A true IL99012A (en) 1996-07-23

Family

ID=9399281

Family Applications (2)

Application Number Title Priority Date Filing Date
IL9901291A IL99012A (en) 1990-07-31 1991-07-30 N-sulfonylindoline derivatives their preparation and pharmaceutical compositions containing them
IL11493495A IL114934A0 (en) 1990-07-31 1995-08-15 N-substituted sulfonylaminobenzene derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11493495A IL114934A0 (en) 1990-07-31 1995-08-15 N-substituted sulfonylaminobenzene derivatives

Country Status (17)

Country Link
EP (1) EP0469984B1 (de)
JP (1) JP3195381B2 (de)
KR (1) KR100211434B1 (de)
AT (1) ATE129236T1 (de)
AU (2) AU645585B2 (de)
CA (1) CA2048139C (de)
DE (1) DE69113911T2 (de)
ES (1) ES2080922T3 (de)
FI (1) FI97224C (de)
FR (1) FR2665441B1 (de)
HU (1) HU220765B1 (de)
IE (1) IE73452B1 (de)
IL (2) IL99012A (de)
NO (1) NO175254C (de)
NZ (1) NZ239182A (de)
PT (1) PT98476B (de)
ZA (1) ZA916031B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
US5481005A (en) * 1990-07-31 1996-01-02 Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
US5338755A (en) * 1990-07-31 1994-08-16 Elf Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
JPH09500133A (ja) * 1993-07-16 1997-01-07 メルク エンド カンパニー インコーポレーテッド オキシトシンのアンタゴニストである置換ピペラジニル樟脳誘導体
ATE216580T1 (de) * 1993-07-16 2002-05-15 Merck & Co Inc Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten
FR2708608B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2714378B1 (fr) * 1993-12-24 1996-03-15 Sanofi Sa Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
GB9918684D0 (en) * 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US7312358B2 (en) 2000-10-17 2007-12-25 Laboratoires Serono Sa Pharmaceutically active sulfanilide derivatives
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
GB0116594D0 (en) 2001-07-06 2001-08-29 Cancer Res Ventures Ltd Therapeutic compounds
WO2003053437A1 (en) 2001-12-20 2003-07-03 Applied Research Systems Ars Holding N.V. Triazoles as oxytocin antagonists
EP2399903A1 (de) * 2002-05-24 2011-12-28 Millennium Pharmaceuticals, Inc. CCR9-Hemmer und Verwendungsverfahren dafür
ES2330205T3 (es) * 2002-12-20 2009-12-07 Cancer Research Technology Limited Compuestos de 4-1-(sulfonil)-1h-indol-2-yl)-4-hydroxi-ciclohexa-2,5-dienona y analogos de los mismos como agentes terapeuticos.
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
FR2880023B1 (fr) 2004-12-23 2007-02-23 Sanofi Aventis Sa Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
FR2927625B1 (fr) 2008-02-19 2010-03-12 Sanofi Aventis Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2930249B1 (fr) 2008-04-21 2010-05-14 Sanofi Aventis Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.
CN116514868A (zh) * 2022-01-20 2023-08-01 华创合成制药股份有限公司 一种用于治疗的磺酰胺类化合物其及制备方法和用途
WO2025124698A1 (en) 2023-12-12 2025-06-19 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists
WO2025224168A1 (en) 2024-04-24 2025-10-30 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838167A (en) * 1972-08-01 1974-09-24 Lilly Co Eli Process for preparing indoles
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
DE3705934A1 (de) * 1987-02-25 1988-09-08 Nattermann A & Cie Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8820129D0 (en) * 1988-08-24 1988-09-28 Schering Agrochemicals Ltd Fungicides
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
JPH04234361A (ja) 1992-08-24
JP3195381B2 (ja) 2001-08-06
HU912552D0 (en) 1992-01-28
CA2048139C (en) 2002-02-12
IE912696A1 (en) 1992-02-12
IE73452B1 (en) 1997-06-04
ATE129236T1 (de) 1995-11-15
IL99012A0 (en) 1992-07-15
IL114934A0 (en) 1995-12-08
ES2080922T3 (es) 1996-02-16
FR2665441B1 (fr) 1992-12-04
DE69113911T2 (de) 1996-03-28
NO175254B (no) 1994-06-13
EP0469984A3 (de) 1992-03-11
FI913614A0 (fi) 1991-07-29
AU5047393A (en) 1994-01-13
CA2048139A1 (en) 1992-02-01
PT98476A (pt) 1992-05-29
EP0469984A2 (de) 1992-02-05
NO175254C (no) 1994-09-21
PT98476B (pt) 1997-10-31
KR100211434B1 (ko) 1999-08-02
FI97224C (fi) 1996-11-11
FI913614L (fi) 1992-02-01
DE69113911D1 (de) 1995-11-23
NZ239182A (en) 1995-07-26
AU645585B2 (en) 1994-01-20
AU664491B2 (en) 1995-11-16
NO912970L (no) 1992-02-03
AU8147891A (en) 1992-02-06
FR2665441A1 (fr) 1992-02-07
EP0469984B1 (de) 1995-10-18
HU220765B1 (hu) 2002-05-28
HUT59669A (en) 1992-06-29
ZA916031B (en) 1992-04-29
FI97224B (fi) 1996-07-31
NO912970D0 (no) 1991-07-30
KR920002537A (ko) 1992-02-28

Similar Documents

Publication Publication Date Title
AU664491B2 (en) Intermediates useful in the preparation of N-sulfonyl-indoline derivatives
AU658664B2 (en) Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them
US5338755A (en) N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
US7348448B2 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
US5481005A (en) N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
TW201602102A (zh) 組織蛋白酶半胱胺酸蛋白酶抑制劑
JPS63290868A (ja) ジケトピペラジン誘導体およびその塩類
NZ248566A (en) Sulphonic acid amide derivatives
WO1994018165A1 (en) Sulfonamide compounds as opioid k-receptor agonists
HK1008741B (en) Indoline derivatives carrying an amide function, their preparation and pharmaceutical compositions containing them
IL114934A (en) N-substituted sulfonylaminobenzene derivatives
HU180103B (en) Process for producing analogues of 9,11,15-trideoxy-prostaglandine-f
CN101238111A (zh) 用于治疗阿尔茨海默氏病的环缩酮β-分泌酶抑制剂
CN119546577A (zh) G蛋白偶联受体88的调节剂
JPH0859581A (ja) シクロヘキサジエン誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees